ReviewHematology. American Society of Hematology. Education Program2018
Pediatric ITP: is it different from adult ITP?
Review in Hematology. American Society of Hematology. Education Program, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 84 citations in OpenAlex.
- Increased percentages of circulating T follicular helper cells associate with disease subtype and activity in pediatric immune cytopenias.Haematologica · 2026Article
- Incidence of systemic lupus erythematosus in patients with immune thrombocytopenia: A nationwide study.British journal of haematology · 2026Article
- No increased risk of hepatic enzyme abnormalities with non-peptidic thrombopoietin receptor agonists in immune thrombocytopenia: A meta-analysis of randomized controlled trials.Experimental and therapeutic medicine · 2026Article
- Patient and Physician Experiences in Immune Thrombocytopenia.Advances in therapy · 2026Article
- Analysis of the Mediating Effect of Vitamin D via the TGF-β1/Treg Pathway in the Pathogenesis of Childhood Primary Immune Thrombocytopenia.Journal of immunology research · 2026Article
- Clinical characteristics and decreased CD4Frontiers in immunology · 2026Article
- Thromboelastography-Guided Laparoscopic Splenectomy in a Patient With Immune Thrombocytopenia and Recent Drug-Eluting Stent Placement: A Case Report.Case reports in anesthesiology · 2026Article
- Prognostic Re-evaluation of Antinuclear Antibodies in Childhood Immune Thrombocytopenia.TH open : companion journal to thrombosis and haemostasis · 2026Article
- Clinical and Laboratory Characteristics of Children with Chronic Idiopathic Thrombocytopenic Purpura.Diagnostics (Basel, Switzerland) · 2025Article
- Pentavalent Vaccine-Induced Immune Thrombocytopenia: A Case Report From Nepal.Clinical case reports · 2025Article
- Experience with Pediatric Chronic Immune Thrombocytopenia over 30 Years in the Era before Eltrombopag.Children (Basel, Switzerland) · 2024Article
- Splenomegaly and Response to Splenectomy in Immune Thrombocytopenia.Journal of clinical medicine · 2024Article
- The miR-641-STIM1 and SATB1 axes play important roles in the regulation of the Th17/Treg balance in ITP.Scientific reports · 2024Article
- Article
- HLA-DRB5 promotes immune thrombocytopenia via activating CD8Open medicine (Warsaw, Poland) · 2024Article
- Adolescents and young adults with newly diagnosed primary immune thrombocytopenia.Haematologica · 2023Article
- Mitral valve replacement in patients of rheumatic heart disease associated with immune thrombocytopenia.Indian journal of thoracic and cardiovascular surgery · 2023Article
- Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP.Blood advances · 2023Review
- Immune thrombocytopenia in the setting of acute SARS-CoV-2 infection.BMJ case reports · 2023Article
- Immune thrombocytopenic purpura secondary to varicella zoster virus.BMJ case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune thrombocytopenia (ITP) has historically been thought to occur in 2 distinct forms: childhood ITP and adult ITP. This division is based largely on the presumption that childhood ITP is often benign and self-limited, whereas ITP in adults tends to be more chronic and difficult to treat. Although data exist to justify a different approach to the diagnosis and treatment in young children and the elderly, ITP in older children, adolescents, and younger adults is likely to share more similar pathology. This article will highlight the most recent data describing the natural history, diagnostic approach, management strategies, and disease-related outcomes in children and adults with ITP. These data reveal many unexpected similarities between the 2 groups, while confirming some of the more well-described differences. Discussion of these findings aims to highlight similarities and differences between ITP in children and adults, which will underscore important areas of future research and/or changes in management guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.